Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 41: 361-366, 1995;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andersson, A.
Right arrow Articles by Hultberg, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andersson, A.
Right arrow Articles by Hultberg, B.

Clinical Chemistry, Vol 41, 361-366, Copyright © 1995 by American Association for Clinical Chemistry

Effect of thiol oxidation and thiol export from erythrocytes on determination of redox status of homocysteine and other thiols in plasma from healthy subjects and patients with cerebral infarction

A Andersson, A Lindgren and B Hultberg
Department of Clinical Chemistry, University Hospital, Lund, Sweden.

Changes in concentration of reduced and oxidized low-M(r) thiols were measured in blood and plasma before and after the separation of blood cells. If centrifugation of blood was postponed, the reduced form of homocysteine in plasma increased with time at 22 degrees C; in contrast, the concentrations of other reduced thiols (cysteine, glutathione, and cysteinylglycine) decreased. In plasma the reduced forms of all thiols disappeared at a rate that followed first-order kinetics. The rates of disappearance ("half-lives") were temperature- dependent; they were about the same for glutathione and homocysteine (11.7 and 14.3 min, respectively, at 22 degrees C) and somewhat higher for cysteinylglycine and cysteine. After establishing proper sampling conditions for reduced thiols, we measured this thiol fraction as well as free (non-protein-bound) and total thiols in 10 reference subjects and 19 patients with cerebral infarction. Mild but significant hyperhomocysteinemia involving total and free homocysteine (but not reduced homocysteine) was found in the patients.


The following articles in journals at HighWire Press have cited this article:


Home page
 CLIN APPL THROMB HEMOSTHome page
I. V. Mohan, I. A. Jagroop, D. P. Mikhailidis, and G. P. Stansby
Homocysteine Activates Platelets In Vitro
Clinical and Applied Thrombosis/Hemostasis, January 1, 2008; 14(1): 8 - 18.
[Abstract] [PDF]

Home page
 ANGIOLOGYHome page
A. B. Sobol, E. Bald, and J. Loba
Fractions of Total Plasma Homocysteine in Patients with Ischemic Stroke Before the Age of 55 Years
Angiology, March 1, 2005; 56(2): 201 - 209.
[Abstract] [PDF]

Home page
 ANGIOLOGYHome page
P. Lind, B. Hedblad, B. Hultberg, L. Stavenow, L. Janzon, and F. Lindgarde
Risk of Myocardial Infarction in Relation to Plasma Levels of Homocysteine and Inflammation-Sensitive Proteins: A Long-Term Nested Case-Control Study
Angiology, July 1, 2003; 54(4): 401 - 410.
[Abstract] [PDF]

Home page
 J. Neurosci.Home page
H. Sato, M. Tamba, S. Okuno, K. Sato, K. Keino-Masu, M. Masu, and S. Bannai
Distribution of Cystine/Glutamate Exchange Transporter, System xc-, in the Mouse Brain
J. Neurosci., September 15, 2002; 22(18): 8028 - 8033.
[Abstract] [Full Text] [PDF]

Home page
 Vasc MedHome page
N. Weiss, C. Keller, U. Hoffmann, and J. Loscalzo
Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia
Vascular Medicine, August 1, 2002; 7(3): 227 - 239.
[Abstract] [PDF]

Home page
 Clin. Chem.Home page
R. H. Williams, J. A. Maggiore, R. D. Reynolds, and C. M. Helgason
Novel Approach for the Determination of the Redox Status of Homocysteine and Other Aminothiols in Plasma from Healthy Subjects and Patients with Ischemic Stroke
Clin. Chem., June 1, 2001; 47(6): 1031 - 1039.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
W. Herrmann, H. Schorr, K. Purschwitz, F. Rassoul, and V. Richter
Total Homocysteine, Vitamin B12, and Total Antioxidant Status in Vegetarians
Clin. Chem., June 1, 2001; 47(6): 1094 - 1101.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Andersson, A. Lindgren, M. Arnadottir, H. Prytz, and B. Hultberg
Thiols as a Measure of Plasma Redox Status in Healthy Subjects and in Patients with Renal or Liver Failure
Clin. Chem., July 1, 1999; 45(7): 1084 - 1087.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
A. Gardemann, H. Weidemann, M. Philipp, N. Katz, H. Tillmanns, F. W. Hehrlein, and W. Haberbosch
The TT genotype of the methylenetetrahydrofolate reductase C677T gene polymorphism is associated with the extent of coronary atherosclerosis in patients at high risk for coronary artery disease
Eur. Heart J., April 2, 1999; 20(8): 584 - 592.
[Abstract] [PDF]

Home page
 NEJMHome page
G. N. Welch and J. Loscalzo
Homocysteine and Atherothrombosis
N. Engl. J. Med., April 9, 1998; 338(15): 1042 - 1050.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. R. Upchurch Jr., G. N. Welch, A. J. Fabian, J. E. Freedman, J. L. Johnson, J. F. Keaney Jr., and J. Loscalzo
Homocyst(e)ine Decreases Bioavailable Nitric Oxide by a Mechanism Involving Glutathione Peroxidase
J. Biol. Chem., July 4, 1997; 272(27): 17012 - 17017.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Sengupta, H. Chen, T. Togawa, P. M. DiBello, A. K. Majors, B. Budy, M. E. Ketterer, and D. W. Jacobsen
Albumin Thiolate Anion Is an Intermediate in the Formation of Albumin-S-S-Homocysteine
J. Biol. Chem., August 3, 2001; 276(32): 30111 - 30117.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Association for Clinical Chemistry.